![]()
|
|
||||||||
(Received for publication, April 17, 1997, and in revised form, June 24, 1997)
From the The synthesis and secretion of factor H, a
regulatory protein of the complement system, were studied in skin
fibroblasts from an H-deficient child who has chronic
hypocomplementemic renal disease. In normal fibroblasts, factor H
transcripts of 4.3 and 1.8 kilobase pairs (kb) encode a 155-kDa protein
containing short consensus repeat (SCR) domains 1-20 and a 45-kDa
protein which contains SCRs 1-7, respectively. The patient's
fibroblasts expressed normal amounts of the 4.3- and 1.8-kb messages
constitutively and after tumor necrosis factor-
Volume 272, Number 40,
Issue of October 3, 1997
pp. 25168-25175
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
MUTATIONS IN FRAMEWORK CYSTEINE RESIDUES AND BLOCK IN H PROTEIN
SECRETION AND INTRACELLULAR CATABOLISM
,
,
,
,
Department of Pediatrics, Washington
University School of Medicine, St. Louis, Missouri 63110, ¶ Department of Pediatrics, the University of
Minnesota, Minneapolis, Minnesota 55455, and
Specialty
Laboratories, Inc., Santa Monica, California 90404
/interferon-
stimulation. Lysates of [35S]methionine-labeled
fibroblasts from the patient contained the 155- and 45-kDa H
polypeptides, but secretion of the 155-kDa protein was blocked; the
45-kDa protein was secreted with normal kinetics. The patient's plasma
lacked the 155-kDa protein but contained the small form of H. Moreover,
in fibroblasts the retained 155-kDa factor H protein was not degraded,
even after 12 h. Immunoflourescent staining and confocal
microscopic imaging of the patient's fibroblasts indicated that factor
H was retained in the endoplasmic reticulum. Sequence analysis of
reverse transcription-polymerase chain reaction products (the entire
coding region) and genomic DNA revealed a T1679C substitution on one
allele and a G2949A substitution on the other (C518R mutation in SCR 9 and C991Y mutation in SCR 16, respectively). Both mutations affect
conserved cysteine residues characteristic of SCR modules and therefore
predict profound changes in the higher order structure of the 155-kDa
factor H protein. These data provide the first description of a
molecular mechanism for factor H deficiency and yield important
insights into the normal secretory pathway for this and other plasma
proteins with SCR motifs.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A.-l. Stahl, F. Vaziri-Sani, S. Heinen, A.-C. Kristoffersson, K.-H. Gydell, R. Raafat, A. Gutierrez, O. Beringer, P. F. Zipfel, and D. Karpman Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation Blood, June 1, 2008; 111(11): 5307 - 5315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Caprioli and G. Remuzzi A mouse model of non-Shiga toxin-associated haemolytic uraemic syndrome Nephrol. Dial. Transplant., February 1, 2008; 23(2): 462 - 465. [Full Text] [PDF] |
||||
![]() |
S. MERI Loss of Self-Control in the Complement System and Innate Autoreactivity Ann. N.Y. Acad. Sci., August 1, 2007; 1109(1): 93 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Alexander, Y. Wang, A. Chang, A. Jacob, A. W.M. Minto, M. Karmegam, M. Haas, and R. J. Quigg Mouse Podocyte Complement Factor H: The Functional Analog to Human Complement Receptor 1 J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1157 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Abrera-Abeleda, C Nishimura, J L H Smith, S Sethi, J L McRae, B F Murphy, G Silvestri, C Skerka, M Jozsi, P F Zipfel, et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) J. Med. Genet., July 1, 2006; 43(7): 582 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Appel, H. T. Cook, G. Hageman, J. C. Jennette, M. Kashgarian, M. Kirschfink, J. D. Lambris, L. Lanning, H. U. Lutz, S. Meri, et al. Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1392 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Dragon-Durey, V. Fremeaux-Bacchi, C. Loirat, J. Blouin, P. Niaudet, G. Deschenes, P. Coppo, W. Herman Fridman, and L. Weiss Heterozygous and Homozygous Factor H Deficiencies Associated with Hemolytic Uremic Syndrome or Membranoproliferative Glomerulonephritis: Report and Genetic Analysis of 16 Cases J. Am. Soc. Nephrol., March 1, 2004; 15(3): 787 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hellwage, T. S. Jokiranta, M. A. Friese, T. U. Wolk, E. Kampen, P. F. Zipfel, and S. Meri Complement C3b/C3d and Cell Surface Polyanions Are Recognized by Overlapping Binding Sites on the Most Carboxyl-Terminal Domain of Complement Factor H J. Immunol., December 15, 2002; 169(12): 6935 - 6944. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Hegasy, T. Manuelian, K. Hogasen, J. H. Jansen, and P. F. Zipfel The Molecular Basis for Hereditary Porcine Membranoproliferative Glomerulonephritis Type II: Point Mutations in the Factor H Coding Sequence Block Protein Secretion Am. J. Pathol., December 1, 2002; 161(6): 2027 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. CAPRIOLI, P. BETTINAGLIO, P. F. ZIPFEL, B. AMADEI, E. DAINA, S. GAMBA, C. SKERKA, N. MARZILIANO, G. REMUZZI, and M. NORIS The Molecular Basis of Familial Hemolytic Uremic Syndrome: Mutation Analysis of Factor H Gene Reveals a Hot Spot in Short Consensus Repeat 20 J. Am. Soc. Nephrol., February 1, 2001; 12(2): 297 - 307. [Abstract] [Full Text] |
||||
![]() |
B. Z. Schmidt, N. L. Fowler, T. Hidvegi, D. H. Perlmutter, and H. R. Colten Disruption of Disulfide Bonds Is Responsible for Impaired Secretion in Human Complement Factor H Deficiency J. Biol. Chem., April 23, 1999; 274(17): 11782 - 11788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. NORIS, P. RUGGENENTI, A. PERNA, S. ORISIO, J. CAPRIOLI, C. SKERKA, B. VASILE, P. F. ZIPFEL, and G. REMUZZI Hypocomplementemia Discloses Genetic Predisposition to Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: Role of Factor HAbnormalities J. Am. Soc. Nephrol., February 1, 1999; 10(2): 281 - 293. [Abstract] [Full Text] |
||||
![]() |
Z.-B. Zhu, T. P. Atkinson, and J. E. Volanakis A Novel Type II Complement C2 Deficiency Allele in an African-American Family J. Immunol., July 15, 1998; 161(2): 578 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Jokiranta, J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri Each of the Three Binding Sites on Complement Factor H Interacts with a Distinct Site on C3b J. Biol. Chem., September 1, 2000; 275(36): 27657 - 27662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Alexander, B. K. Hack, P. N. Cunningham, and R. J. Quigg A Protein with Characteristics of Factor H Is Present on Rodent Platelets and Functions as the Immune Adherence Receptor J. Biol. Chem., August 17, 2001; 276(34): 32129 - 32135. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |